Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sonja Hiemer"'
Autor:
Iryna Manuilova, Jan Bossenz, Annemarie Bianka Weise, Dominik Boehm, Cosima Strantz, Philipp Unberath, Niklas Reimer, Patrick Metzger, Thomas Pauli, Silke D Werle, Susann Schulze, Sonja Hiemer, Arsenij Ustjanzew, Hans A Kestler, Hauke Busch, Benedikt Brors, Jan Christoph
Publikováno v:
JMIR Research Protocols, Vol 13, p e58705 (2024)
BackgroundUnderstanding the similarities of patients with cancer is essential to advancing personalized medicine, improving patient outcomes, and developing more effective and individualized treatments. It enables researchers to discover important pa
Externí odkaz:
https://doaj.org/article/ee8f1cc375034ca5ac0d58a630db6022
Autor:
Friederike Braulke, Servet Para, Bernd Alt-Epping, Mitra Tewes, Markus Bäumer, Birgit Haberland, Regine Mayer-Steinacker, Anne Hopprich, Maike de Wit, Michaela Grabe, Sophia Bender-Säbelkampf, Caroline Weßling, Christoph Aulmann, Christina Gerlach, Pascale Regincos, Ferdinand Fischer, Soraya Haarmann, Tatjana Huys, Sabine Drygas, Anett Rambau, Alexander Kiani, Astrid Schnabel, Christoph Buhl, Stefanie Seipke, Sonja Hiemer, Silke Polata, Maximilian Meßmann, Anna Hansmeier, Louiza Anastasiadou, Anne Letsch, Daniel Wecht, Matthias Hellberg-Naegele, Utz Krug, Ulrich Wedding, Birgitt van Oorschot
Purpose Guidelines recommend a structured symptom screening (SC) for especially advanced cancer patients (CPs). The aim of this multicenter German prospective quality assurance project KeSBa (Kennzahl Symptom- und Belastungserfassung) was to gain kno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca3ec27bf7dfe0d9ddd7d28c02176217
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85158140937
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85158140937
Publikováno v:
Drugs. 71:2257-2275
Adjuvant chemotherapy after resection of the primary tumour reduces the risk of death by an absolute 5% in UICC (Union Internationale Contre le Cancer) stage II colon cancer and about 15-20% in stage III. Adjuvant treatment has to be evaluated separa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5110ebad3e750a9f202177bb5a4c6fb
https://doi.org/10.2165/11594490-000000000-00000
https://doi.org/10.2165/11594490-000000000-00000
Publikováno v:
Onkologie. 35:440-442
Background: Patients with solid tumors have an increased risk of venous thromboembolism, potentially related to a venous port system. In case of catheter-related thrombosis despite full anticoagulation, further treatment administration is difficult.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d4b3d80abe9de6c8844cc31bd865091
https://doi.org/10.1159/000341083
https://doi.org/10.1159/000341083
Publikováno v:
Onkologie. 35(7-8)
Patients with solid tumors have an increased risk of venous thromboembolism, potentially related to a venous port system. In case of catheter-related thrombosis despite full anticoagulation, further treatment administration is difficult.A 41-year-old
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a0b9f56403b3c6ab135e461a07346e3e
https://pubmed.ncbi.nlm.nih.gov/22846976
https://pubmed.ncbi.nlm.nih.gov/22846976